HLSE:TTALO

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Market Cap

€1.5b

Last Updated

2021/06/15 07:12 UTC

Data Sources

Company Financials +

Executive Summary

Terveystalo Oyj provides occupational healthcare services in Finland. More Details


Snowflake Analysis

Solid track record and good value.

Share Price & News

How has Terveystalo Oyj's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: TTALO is less volatile than 75% of Finnish stocks over the past 3 months, typically moving +/- 3% a week.

Volatility Over Time: TTALO's weekly volatility (3%) has been stable over the past year.


Market Performance


7 Day Return

1.0%

TTALO

0.9%

FI Healthcare

0.5%

FI Market


1 Year Return

26.7%

TTALO

12.4%

FI Healthcare

32.1%

FI Market

Return vs Industry: TTALO exceeded the Finnish Healthcare industry which returned 12.4% over the past year.

Return vs Market: TTALO underperformed the Finnish Market which returned 32.1% over the past year.


Shareholder returns

TTALOIndustryMarket
7 Day1.0%0.9%0.5%
30 Day0.5%3.7%4.1%
90 Day2.4%14.8%7.8%
1 Year30.0%26.7%15.6%12.4%38.5%32.1%
3 Year17.9%12.5%-3.1%-8.1%40.9%18.9%
5 Yearn/a4.7%-2.9%90.6%52.3%

Long-Term Price Volatility Vs. Market

How volatile is Terveystalo Oyj's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Terveystalo Oyj undervalued compared to its fair value and its price relative to the market?

33.1%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: TTALO (€11.78) is trading below our estimate of fair value (€17.62)

Significantly Below Fair Value: TTALO is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: TTALO is good value based on its PE Ratio (24.6x) compared to the European Healthcare industry average (31.8x).

PE vs Market: TTALO is good value based on its PE Ratio (24.6x) compared to the Finnish market (25.2x).


Price to Earnings Growth Ratio

PEG Ratio: TTALO is poor value based on its PEG Ratio (2.7x)


Price to Book Ratio

PB vs Industry: TTALO is overvalued based on its PB Ratio (2.6x) compared to the XE Healthcare industry average (2.4x).


Future Growth

How is Terveystalo Oyj forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?

9.1%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: TTALO's forecast earnings growth (9.1% per year) is above the savings rate (0.2%).

Earnings vs Market: TTALO's earnings (9.1% per year) are forecast to grow slower than the Finnish market (11.6% per year).

High Growth Earnings: TTALO's earnings are forecast to grow, but not significantly.

Revenue vs Market: TTALO's revenue (4.5% per year) is forecast to grow faster than the Finnish market (3.5% per year).

High Growth Revenue: TTALO's revenue (4.5% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: TTALO's Return on Equity is forecast to be low in 3 years time (12.8%).


Past Performance

How has Terveystalo Oyj performed over the past 5 years?

24.8%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: TTALO has high quality earnings.

Growing Profit Margin: TTALO's current net profit margins (6%) are higher than last year (4.5%).


Past Earnings Growth Analysis

Earnings Trend: TTALO's earnings have grown significantly by 24.8% per year over the past 5 years.

Accelerating Growth: TTALO's earnings growth over the past year (33%) exceeds its 5-year average (24.8% per year).

Earnings vs Industry: TTALO earnings growth over the past year (33%) exceeded the Healthcare industry 13.7%.


Return on Equity

High ROE: TTALO's Return on Equity (10.5%) is considered low.


Financial Health

How is Terveystalo Oyj's financial position?


Financial Position Analysis

Short Term Liabilities: TTALO's short term assets (€202.6M) do not cover its short term liabilities (€322.4M).

Long Term Liabilities: TTALO's short term assets (€202.6M) do not cover its long term liabilities (€480.2M).


Debt to Equity History and Analysis

Debt Level: TTALO's debt to equity ratio (64.2%) is considered high.

Reducing Debt: TTALO's debt to equity ratio has reduced from 138.3% to 64.2% over the past 5 years.

Debt Coverage: TTALO's debt is well covered by operating cash flow (38.1%).

Interest Coverage: TTALO's interest payments on its debt are well covered by EBIT (8.9x coverage).


Balance Sheet


Dividend

What is Terveystalo Oyj current dividend yield, its reliability and sustainability?

1.10%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: TTALO's dividend (1.1%) isn’t notable compared to the bottom 25% of dividend payers in the Finnish market (1.66%).

High Dividend: TTALO's dividend (1.1%) is low compared to the top 25% of dividend payers in the Finnish market (3.62%).


Stability and Growth of Payments

Stable Dividend: TTALO is not paying a notable dividend for the Finnish market, therefore no need to check if payments are stable.

Growing Dividend: TTALO is not paying a notable dividend for the Finnish market, therefore no need to check if payments are increasing.


Current Payout to Shareholders

Dividend Coverage: TTALO is not paying a notable dividend for the Finnish market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of TTALO's dividend in 3 years as they are not forecast to pay a notable one for the Finnish market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

1.5yrs

Average management tenure


CEO

Ville Iho (51 yo)

1.5yrs

Tenure

€366,667

Compensation

Mr. Ville Iho has been President & CEO of Terveystalo Oyj since December 6, 2019. Mr. Iho served as Chief Executive Officer at Nurminen Logistics Oyj since March 18, 2019 until December 05, 2019 and its Pr...


CEO Compensation Analysis

Compensation vs Market: Ville's total compensation ($USD443.53K) is below average for companies of similar size in the Finnish market ($USD1.00M).

Compensation vs Earnings: Ville's compensation has increased by more than 20% in the past year.


Leadership Team

Experienced Management: TTALO's management team is not considered experienced ( 1.5 years average tenure), which suggests a new team.


Board Members

Experienced Board: TTALO's board of directors are not considered experienced ( 2.2 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Terveystalo Oyj's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Terveystalo Oyj
  • Ticker: TTALO
  • Exchange: HLSE
  • Founded: 2001
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: €1.500b
  • Shares outstanding: 127.31m
  • Website: https://www.terveystalo.com

Number of Employees


Location

  • Terveystalo Oyj
  • Jaakonkatu 3 B
  • 3rd Floor
  • Helsinki
  • Uusimaa
  • 100
  • Finland

Listings


Biography

Terveystalo Oyj provides occupational healthcare services in Finland. The company offers general practice and specialist medical care, diagnostic, outpatient surgery, dental, and other adjacent services; a...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/06/15 07:12
End of Day Share Price2021/06/14 00:00
Earnings2021/03/31
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.